22
Participants
Start Date
November 3, 2022
Primary Completion Date
December 3, 2024
Study Completion Date
December 3, 2029
Luspatercept Injection [Reblozyl]
"Eligible subjects will receive luspatercept (ACE-536): starting dose of 1.0 mg/kg subcutaneous injection every 3 weeks (21 days; Q3W). Dose levels can be increased in a stepwise manner beyond the starting dose to 1.33 mg/kg, and up to a maximum of 1.75 mg/kg (with a maximum total dose of 168 mg).~All subjects who have received at least one dose of luspatercept should undergo follow-up evaluations after day 169 with Assessment visits every 24 weeks (168 days) up to 2 years to evaluate evidence of clinical benefit."
RECRUITING
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria
NOT_YET_RECRUITING
A.O. SS. Antonio e Biagio e Cesare Arrigo Ospedale Civile, Alessandria
RECRUITING
A.O.U. Ospedali Riuniti, Ancona
NOT_YET_RECRUITING
A.O. S. Giuseppe Moscati, Avellino
NOT_YET_RECRUITING
Ospedale degli Infermi, Biella
NOT_YET_RECRUITING
A.O.U. G. Rodolico San Marco, Catania
NOT_YET_RECRUITING
ARNAS Garibaldi, PO Nesima, Catania
NOT_YET_RECRUITING
ASL TO 4 - Ospedale Chivasso, Chivasso
NOT_YET_RECRUITING
Azienda Ospedaliera Annunziata, Cosenza
NOT_YET_RECRUITING
A.O.U. Careggi, Florence
NOT_YET_RECRUITING
A.O.U. Federico II, Napoli
NOT_YET_RECRUITING
A.O.U. Maggiore della Carità, Novara
NOT_YET_RECRUITING
A.O.U. Policlinico Paolo Giaccone, Palermo
NOT_YET_RECRUITING
Ospedale Civile Spirito Santo, Pescara
NOT_YET_RECRUITING
IRCCS di Reggio Emilia, Reggio Emilia
NOT_YET_RECRUITING
Ospedale S. Eugenio, Roma
NOT_YET_RECRUITING
Policlinico Tor Vergata, Roma
NOT_YET_RECRUITING
Policlinico Umberto I, Roma
NOT_YET_RECRUITING
A.O.U. San Giovanni di Dio e Ruggì D'Aragona, Salerno
NOT_YET_RECRUITING
Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo
NOT_YET_RECRUITING
AO Santa Maria di Terni, Terni
NOT_YET_RECRUITING
A.O. Città della Salute e della Scienza, Torino
NOT_YET_RECRUITING
ASU Giuliano Isontina, Trieste
Associazione Qol-one
OTHER